Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janine E Collinge

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Opinion in Ophthalmology|July 23, 2013
Update in pediatric optic neuritisJanine E Collinge, Derek T Sprunger
Experimental Eye Research|June 28, 2005
Expression of tissue plasminogen activator during eye developmentJanine E Collinge, Vladimir N Simirskii, Melinda K Duncan
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|August 4, 2015
Outcome of pediatric patients referred for papilledemaJessica J Kovarik, Poonam N Doshi, Janine E Collinge, et al.
JAMA Ophthalmology|November 8, 2019
Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of PrematurityEric R Crouch, Raymond T Kraker, David K Wallace, et al.
Ophthalmology|April 1, 2022
The Pediatric Optic Neuritis Prospective Outcomes Study: Two-Year ResultsStacy L Pineles, Robert J Henderson, Michael X Repka, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Opinion in Ophthalmology|July 23, 2013
Update in pediatric optic neuritisJanine E Collinge, Derek T Sprunger
Experimental Eye Research|June 28, 2005
Expression of tissue plasminogen activator during eye developmentJanine E Collinge, Vladimir N Simirskii, Melinda K Duncan
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|August 4, 2015
Outcome of pediatric patients referred for papilledemaJessica J Kovarik, Poonam N Doshi, Janine E Collinge, et al.
JAMA Ophthalmology|November 8, 2019
Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of PrematurityEric R Crouch, Raymond T Kraker, David K Wallace, et al.
Ophthalmology|April 1, 2022
The Pediatric Optic Neuritis Prospective Outcomes Study: Two-Year ResultsStacy L Pineles, Robert J Henderson, Michael X Repka, et al.
Pageof 1